Legacy Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.23M Sell
13,555
-299
-2% -$26.8K 0.13% 137
2024
Q4
$1.11M Buy
13,854
+173
+1% +$15K 0.11% 147
2024
Q3
$1.23M Buy
13,681
+648
+5% +$54.5K 0.13% 127
2024
Q2
$1.03M Sell
13,033
-698
-5% -$57.2K 0.13% 125
2024
Q1
$1.21M Sell
13,731
-10,338
-43% -$882K 0.15% 119
2023
Q4
$2M Sell
24,069
-5,032
-17% -$384K 0.26% 82
2023
Q3
$2.3M Sell
29,101
-356
-1% -$29.8K 0.37% 71
2023
Q2
$2.6M Sell
29,457
-144
-0.5% -$12.4K 0.39% 61
2023
Q1
$2.41M Buy
29,601
+444
+2% +$36.2K 0.44% 56
2022
Q4
$2.29M Buy
29,157
+2,857
+11% +$232K 0.42% 51
2022
Q3
$2.14M Buy
26,300
+1,890
+8% +$170K 0.47% 41
2022
Q2
$2.21M Buy
24,410
+2,215
+10% +$224K 0.46% 39
2022
Q1
$2.48M Buy
+22,195
New +$2.34M 0.48% 35
2019
Q3
Sell
-1,450
Closed -$141K 241
2019
Q2
$141K Buy
1,450
+350
+32% +$32K 0.1% 133
2019
Q1
$100K Buy
+1,100
New +$98.5K 0.03% 155
2018
Q4
Sell
-3,100
Closed -$305K 278
2018
Q3
$305K Buy
3,100
+1,959
+172% +$181K 0.15% 113
2018
Q2
$98K Buy
1,141
+41
+4% +$3.42K 0.07% 138
2018
Q1
$88K Buy
1,100
+100
+10% +$8.25K 0.07% 125
2017
Q4
$81K Hold
1,000
0.08% 97
2017
Q3
$77K Hold
1,000
0.09% 82
2017
Q2
$88K Hold
1,000
0.11% 75
2017
Q1
$80K Hold
1,000
0.11% 73
2016
Q4
$71K Buy
+1,000
New +$78.6K 0.1% 84

Other funds holding MDT

Legacy Advisors's MDT Position: Q1 2025 in Review

Legacy Advisors reduced its Medtronic (MDT) stake by 2.2% in Q1 2025, selling an estimated $26.8K and leaving 13,555 shares worth $1.23M. The position accounts for 0.13% of the portfolio, ranked #137.

Legacy Advisors first reported a position in MDT in Q4 2016 and has held it in 23 quarters since. The position peaked at $2.6M in Q2 2023. 2,177 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Legacy Advisors held 13,555 shares of Medtronic worth $1.23M as of Q1 2025.
  • Legacy Advisors sold 299 Medtronic shares in Q1 2025, an estimated $26.8K.
  • Medtronic made up 0.13% of Legacy Advisors's portfolio in Q1 2025, its #137 holding.
  • Legacy Advisors first reported a position in Medtronic in Q4 2016 and has held it in 23 quarters since.
  • Legacy Advisors's Medtronic position peaked at $2.6M in Q2 2023.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.